Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Van Le L.   Waggoner S.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite

A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the Cervix

By Burnett A.F.   Roman L.D.   Garcia A.A.   Muderspach L.I.   Brader K.R.   Morrow C.P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 63-66

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Arseneau J.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 100-102

Academic Press

Access to resources Recommend Favorite